# PEMETREXED DISODIUM
> **ANDA214436** · Abbreviated New Drug Application (Generic) · Sponsor: BAXTER HLTHCARE CORP · Approved 2022-08-18
## Drug
- **FDA Application Number:** ANDA214436
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PEMETREXED DISODIUM
- **Generic name:** Pemetrexed Disodium
- **Active ingredients:** PEMETREXED DISODIUM
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** BAXTER HLTHCARE CORP
- **First approval:** 2022-08-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214436)
---
*MORVS · CC0 1.0*